Neurofibromatosis Type 1 Dermal Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial

Grant

Date/time Interval

  • July 1, 2016 - June 30, 2019
  • Total Award Amount

  • 484584.00
  • Direct Costs

  • 440531.00
  • Sponsor Award Id

  • Contributor

  • Cannon, Ashley   Principal Investigator  
  • Korf M.D., Ph.D., Bruce   Investigator